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ZebraﬁshDiabetes mellitus (DM) affects over 10% of the world's population. Hyperglycemia is the main feature for the
diagnosis of this disease. The zebraﬁsh (Danio rerio) is an established model organism for the study of various
metabolic diseases. In this paper, hyperglycemic zebraﬁsh, when immersed in a 111 mM glucose solution for
14 days, developed increased glycation of proteins from the eyes, decreased mRNA levels of insulin receptors
in the muscle, and a reversion of high blood glucose level after treatment with anti-diabetic drugs (glimepiride
andmetformin) even after 7 days of glucosewithdrawal. Additionally, hyperglycemic zebraﬁsh developed an im-
paired response to exogenous insulin, which was recovered after 7 days of glucose withdrawal. These data sug-
gest that the exposure of adult zebraﬁsh to high glucose concentration is able to induce persistent metabolic
changes probably underlined by a hyperinsulinemic state and impaired peripheral glucose metabolism.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Diabetesmellitus (DM) is a heterogeneous group ofmetabolic disor-
ders characterized by high levels of blood sugar, termed hyperglycemia
(SBD, 2009). According to the International Diabetes Federation (IDF),
in the year 2012, the estimated number of adults living with diabetes
had soared to 371 million or 8.5% of the global adult population (IDF,
2012). New projected data suggest that until 2030 there will be
552 million people with diabetes; this means for that every 10 s
approximately three more people will be diagnosed with diabetes
(IDF, 2012).
Chronic blood sugar elevation is the major biochemical diagnostic
parameter that is seen in the twomajor forms of diabetes: Type 1 diabe-
tes or insulin-dependent, caused by autoimmune destruction of insulin
producing pancreatic β-cells, and Type 2 diabetes or non-insulin depen-
dent characterized by insulin insensitivity (Harris and Zimmet, 1997).UCRS, Avenida Ipiranga, 6681,
x4158; fax:+55 51 3320 3612.
tti),
l.com (L.W. Kist),
an), rosane.silva@pucrs.brZebraﬁsh has been established as a good animalmodel to understand
physiological and pathological conditions in vertebrates (Maddison and
Chen, 2012; Asaoka et al., 2013; Stewart et al., 2014). Olsen et al.
(2010) described the diabetes model in adult zebraﬁsh via streptozocin
which induces pancreactic cell death, promoting diabetic complications
such as fasting elevated blood glucose values, increased glycation of
serumprotein, retinopathy, decreased serum insulin levels and impaired
regeneration in damaged areas (Oka et al., 2010; Olsen et al., 2010).
Other studies described an obesity model in adult zebraﬁsh, revealing
that the induction of obesity is able to promote hypertriglyceridemia
and hyperglycemia, as common pathophysiological pathways similar
with those found in mammalians (Gleeson et al., 2007; Oka et al.,
2010). Adult zebraﬁsh easily absorb molecules from water, due to an
ability to regulate their internal water and total solute concentrations
(Moyle and Cech, 2000). They operate hyperosmotically, a strategy of os-
moregulation that involves the continuous gain of water as a result of a
higher internal concentration of salt compared to their freshwater envi-
ronment. The constant inﬂux of water results in the uptake of molecules
from their environment. In this way, an easy model of hyperglycemia
was proposed by immersing zebraﬁsh in a glucose solution, being capa-
ble of generating diabetic retinopathy similar to humans (Ferraris and
Ahearn, 1984; Bogé and Péres, 1990; Gleeson et al., 2007; Tseng et al.,
2009; Alvarez et al., 2010). In zebraﬁsh, the glucose absorption/uptake
occurs through a glucose transporter, called GLUT, expressed in the
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et al., 2009). Here we described that glucose overload in living water of
ﬁsh is able to induce symptoms related to the pathophysiology of DM,
which are persistent after a glucose withdrawal period and sensitive to
anti-diabetic drugs.
2. Material and methods
2.1. Animals
Zebraﬁsh (Danio rerio) adult wild type (Tübingen background;
3–5 cm) of both sexeswere acclimated for at least 14 days in the exper-
imental room. Animals were housed in groups of 15 ﬁsh in 5-L
thermostated (28 ± 2 °C) tanks, kept under constant chemical, biolog-
ical and mechanical water ﬁltration and aeration (7.20 mg O2/L). Fish
were maintained under a 14 h/10 h day/night photoperiod cycle, fed
three times a day with commercial ﬂakes containing 48% protein, 8%
fat, and 2% ﬁber (TetraMin™, NC, USA) (Siccardi et al., 2009) and sup-
plemented with live brine shrimp. All ﬁsh used in these experiments
were randomly chosen from different clusters. The animals were sub-
mitted to hypothermia by exposure to ice water, ﬂocked, and followed
by decapitation as the endpoint. Anesthesia with Tricaine MS-222 was
done only in experiments using intraperitoneal injection as described
below. All protocols were approved by the Institutional Animal Care
Committee (12/00310 — CEUA PUCRS) and followed Brazilian legisla-
tion, the guidelines of the Federal Council of Veterinary Medicine
(CFMV), and the Canadian Council for Animal Care (CCAC) “Guide on
the Care and Use of Fish in Research, Teaching, and Testing”.
2.2. Drugs
Treatment concentrations were as follows: Tricaine MS-222
(0.1 g/mL; ethyl 3-aminobenzoate methanesulfonate salt, Fluka™); glu-
cose in three concentrations: 55.5, 111 and 166 mM (w/v) (Nuclear™);
human insulin (0.01, 0.1 and 1 U/kg; Novolin™); metformin chloridate
(10 μM; Merck™) and glimepiride (100 μM; Merck™).
2.3. Induction of hyperglycemia
Groups of 15 adult animals were placed in 5-L aquaria containing
different glucose solutions (55.5, 111 and 166mM), whichwere diluted
in water and maintained during 14 days at room temperature. The
feeding schedule and general maintenance procedures were as already
described in the previous section. The solutions of glucose were ex-
changed three times perweek to avoid contaminationwith opportunis-
tic microorganisms. The animals were placed in each solution and were
monitored for signs of stress such as difﬁculty of swimming or excessive
gill movement (Pedroso et al., 2012). Control and 55.5 and 111 mM
glucose-treated groups showed no signs of stress during all treatment
with low mortality (30% and 20%, respectively), while 166 mM
glucose-treated animals appeared to bemore affected by the treatment,
demonstrating 40% mortality. Control group animals were maintained
in 5-L aquariumswith normal water for the same period and conditions
as the glucose-treated groups. For the following experiments, we chose
the 111mM glucose solution since the survival was the highest and the
proﬁle of blood glucose levelswas similar to those published by Gleeson
et al. (2007).
2.4. Withdrawal of glucose
In order to verify whether the effects caused by 111mMglucose so-
lution treatment would be persistent, we kept a group of 15 ﬁsh in
glucose-free water for an additional 7 days (washout group, no glucose
added). During this period the animals were maintained at the same
conditions of welfare described in the previous section. Control groupanimals were maintained in 5-L aquariumswithwater for the same pe-
riod and were handled as a washout group.
2.5. Determination of blood glucose levels
For all tests with determination of blood glucose levels, before the
beginning of blood collection procedures, ﬁsh were fasted for 12 h and
placed for 15 min in an aquarium with water without glucose to avoid
contamination of the glucometer strip (Gleeson et al., 2007). The proce-
dure of euthanasia occurred after hypothermia induction, which con-
tributes to reduce the variability of blood glucose analyses (Eames
et al., 2010). Immediately, the tail was cut and blood-glucose readings
were taken by placing a glucometer test strip (One-Touch Ultra, Accu
Check) directly on the docked tail. The blood glucose levels were mea-
sured throughout the treatment for 14 days at all concentrations tested
(55.5, 111 and 166 mM glucose-treated groups) and after 7 days of
glucose withdrawal (washout group) (Gleeson et al., 2007).
2.6. Determination of glycated proteins from zebraﬁsh eyes
One of themethods tomonitor glycemic control in humans is through
the levels of non-enzymatic glycation of proteins, such as the determina-
tion of fructosamine levels (Armbruster, 1987). We utilized the enzyme
based fructosamine quantiﬁcation assay (Biotechnical™, RS, Brazil),
with minor adaptation, to document the presence of non-enzymatic
glycation products from zebraﬁsh eyes from all groups. Zebraﬁsh eyes
were removed and washed in water and afterwards placed in 500 μL
of saline and homogenized. Following the manufacturer's instructions,
50 μL samples were added to the 1 mL of reagent containing
200 nmol/L carbonate buffer, and 0.25 nmol/L Blue nitrotetrazol
which were incubated for 10–15 min at 37 °C. The quantiﬁcation of
fructosamine was determined spectrophotometrically at 520 nm and
the concentration was expressed as μmol/L.
2.7. Treatment with anti-diabetic metformin and glimepiride drugs
Glucose-treated and washout animals were submitted to the anti-
diabetic metformin or glimepiride. We dissolved metformin chloridate
in water of ﬁsh to a ﬁnal concentration of 10 μM. The collection of
blood samples was performed after 4 days of treatment (Elo et al.,
2007; Polakof et al., 2011; Polakof and Comte, 2012). For treatment
with glimepiride, we dissolved glimepiride in DMSO (ﬁnal concentra-
tion 0.0005%) and added to water to a ﬁnal concentration of 100 μM.
The collection of blood samples was performed after 24 h of treatment,
due to the results found by Elo et al. (2007). Blood glucose levels were
measuredwith a blood glucometer as described. Salinewas used as con-
trol for the metformin group and 0.0005% (v/v) DMSO solution was
used as control for the glimepiride group. Metformin, glimepiride,
DMSO and saline were freshly prepared on the experimental day.
2.8. Gene expression analysis by quantitative real time RT-PCR (RT-qPCR)
The expression of isoforms of insulin receptor genes (insra-1, insra-2,
insrb-1 and insrb-2) was analyzed by a quantitative real time reverse
transcription polymerase chain reaction (RT-qPCR) assay. TRIzol™ re-
agent (Invitrogen, Carlsbad, CA, USA) was employed to isolate total
RNA from zebraﬁsh skeletal muscle in accordance with the
manufacturer's instructions. The total RNA was quantiﬁed by spectro-
photometry and the cDNA was synthesized with ImProm-II™ Reverse
Transcription System (Promega) from 1 μg of total RNA, following the
manufacturer's instructions. Quantitative PCR was performed using
SYBR®Green I (Invitrogen) to detect double-strand cDNA synthesis. Re-
actions were done in a volume of 25 μL using 12.5 μL of diluted cDNA
(1:50 for reference genes EF1α, Rpl13α and insra-1 and 1:100 for
insra-2, insrb-1, insrb-2), containing SYBR® Green I 0.2 times diluted
(Invitrogen), 100 μM dNTP, 1 × PCR buffer, 3 mM MgCl2, 0.25 U
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reverse and forward primers (Table 1). The PCR cycling conditions
were: an initial polymerase activation step for 5 min at 95 °C, 40 cycles
of 15 s at 95 °C for denaturation, 35 s at 60 °C for annealing, and 15 s at
72 °C for elongation. At the end of the cycling protocol, a melting-curve
analysis was included and ﬂuorescence measured from 60 to 99 °C.
Relative expression levels were determined with 7500 Fast Real-Time
System sequence detection software v.2.0.5 (Applied Biosystems). The
efﬁciency per sample was calculated using LinRegPCR version 2012.3
software (http://LinRegPCR.nl) and the stability of the references
genes, EF1α, and Rpl13α (M-value) and the optimal number of reference
genes according to the pairwise variation (V)were analyzed byGeNorm
3.5 software (http://medgen.ugent.be/genorm/). Relative RNA expres-
sion levels were determined using the 2−ΔΔCT method (Oggier et al.,
2010; Nery et al., 2011).2.9. Response to insulin
Glucose andwashout groupswere checked for the responsiveness to
insulin. Fifteen animals of each group (control, 111mMglucose-treated
and washout) were placed in water without glucose for 24 h before the
beginning of the experiment, in order to prevent interference on the
fasting regimen. After that, ﬁsh were anesthetized in 0.1 mg/mL of
Tricaine MS-222 prior the collection of blood. Fish were considered to
be anesthetized when they presented lack of motor coordination, re-
duced respiration rate and no response to external stimuli (Phelps
et al., 2009). We utilized Novolin™ Insulin Human 100 U/mL in three
different doses: 0.01 U, 0.1 U and 1 U with volume adjusted to the ﬁsh
body weight (injection volume was 10 μL) in a 20 mL/kg regimen.
Intraperitonial injections were conducted using a 3/10-mL U-100 BD
Ultra-Fine™ Short Insulin Syringe 8 mm (5/16″) × 31 G short needles
(Becton Dickinson and Company, New Jersey, USA) according to the
protocol established by Phelps et al. (2009). The needle was inserted
parallel to the spine into the midline of the abdomen, posterior to the
pectoral ﬁns. The injection procedure was conducted to guarantee that
the animals did not spend more than 10 s out of the water. After the in-
jection, the animals were placed in a separate tank with highly aerated
unchlorinated tap water (28 ± 2 °C) to facilitate animal recovery from
anesthesia. Saline was used as control. Both insulin and saline were
freshly prepared on the experimental day. All the animals had recovered
after 2–3 min following the injection. The glycemia was accessed 4 h
after insulin injection as suggested by previous studies using zebraﬁsh
(Olsen et al., 2010). The insulin-treated animals and controls had its
tail cut and the blood collected (Pedroso et al., 2012). Animals were
gently placed in a water-soaked gauze-wrapped hemostat with the ab-
domen facing up and the head of the ﬁsh positioned at the hinge of the
hemostat (the pectoral ﬁns were used as a landmark on the abdomen)
(Phelps et al., 2009).Table 1
Primer sequences for RT-qPCR experiments included in the study.
Sequence Forward Rev
EF1α* 5′-CTGGAGGCCAGCTCAAACAT-3′ 5′-ATCAAGAAGAGTAG
Rpl13α* 5′-TCTGGAGGACTGTAAGAGGTATGC-3′ 5′-AGACGCACAAT
insra-1** 5′-CAACATGCCCCCTCACCACT-3 5′-CGACACACA
insra-2** 5′-GGAGCCCCACTCGTCTAACAAA-3′ 5′-CGCCGTTGTGA
insrb-1** 5′-GACTGATTACTATCGCAAGGG-3′ 5′-TCCAGGTATC
insrb-2** 5′-CCACCGCCAACCCTAAAGGA-3′ 5′-TTGCGATAGTAAT
* Tang et al., (2007).
** Toyoshima et al., (2008).2.10. Statistical analysis
Data were expressed as mean ± standard error of mean. The data
from insulin response experiments were analyzed by student's t-test.
All other data were analyzed by one-way analysis of variance
(ANOVA) followed by post hoc Tukey's considering P b 0.05 as statisti-
cally different for biochemical and mRNA expression experiments in
adult zebraﬁsh.
3. Results
3.1. Chronic treatment with glucose induces persistent hyperglycemia
Our results demonstrated that the immersion in all glucose solution
tested (Fig. 1) provoked up to a 4–5 times increase in blood glucose levels
until the 14th day of treatment in relation to control animals (2.99 ±
0.18 mM) [55.5 mM — F(6; 100) = 25.39, 111 mM — F(6; 100) = 25.57,
166mM— F(6; 101)= 34.72].Weobserved that 20%of the animals treated
with 166 mM glucose died during the treatment, and the next analyses
weremadewith only the 111mMglucose treated animals,which is in ac-
cordance to the zebraﬁsh model of hyperglycemia described by Gleeson
et al. (2007). In order to verify if the effects caused by treatment of
14 days of immersion in 111 mM glucose solution would be persistent,
we performed a glucose withdrawal. Our results demonstrated that
after 7 days of glucose withdrawal, there was a strong reduction (68%)
on blood glucose levels (from 13.52 ± 1.29 mM to 4.26 ± 0.31 mM)
when compared to the 111 mM glucose group, but still almost 2 times
higher than the control group (2.48 ± 0.17 mM) [F(2; 43) = 69.03,
p b 0.001] (Fig. 2). These data show that hyperglycemia can be induced
and maintained in zebraﬁsh.
3.2. Hyperglycemia increases glycation of proteins from zebraﬁsh eyes
In order to demonstrate that treatmentwith glucose for 14 days was
causing persistent glycation of proteins, we analyzed the levels of
fructosamine from zebraﬁsh eyes during glucose treatment and after
glucose withdrawal. Our results demonstrated that the treatment with
111 mM glucose for 14 days was able to increase (41%) fructosamine
levels from zebraﬁsh eyes and also demonstrated that this effect was
prolonged up to 7 days of glucose withdrawal, demonstrating an
increase (40%) in the fructosamine levels from zebraﬁsh eyes in com-
parison to the control group (80.78 ± 8.54 μmol/L) [F(2; 17) = 6.369,
p b 0.05] (Fig. 3).
3.3. Anti-diabetic drugs reduce blood glucose levels from hyperglycemic
zebraﬁsh
To evaluate if hyperglycemic zebraﬁsh would be responsive to
the anti-diabetic drugs, we treated the animals with glimepirideerse Accession number
(mRNA)
Amplicon size (bp)
TACCGCTAGCATTAC-3′ ENSDART00000023156 86
CTTGAGAGCAG-3′ NM_212784.1 147
TGTTGTTGTG-3′ NM_001142672 215
ATGACGTATTC-3′ – 193
CTCCGTCCAT-3′ NM_001123229 190
CAGTC TCGTAAAT-3′ – 170
Fig. 2. Effect of glucose washout on hyperglycemic zebraﬁsh. At least thirteen zebraﬁsh
were used for each group. Data are expressed as mean ± SEM of ten independent
experiments. Data were analyzed by one-way ANOVA followed by Tukey post-hoc test.
The * represents a signiﬁcant difference from the control group. The # represents a signif-
icant difference from the111mMglucose group. *pb 0.05 and ***pb 0.001 and #p b 0.001.
Fig. 3. Effect of 111 mM glucose treatment for 14 days and glucose washout of 7 days on
fructosamine levels in zebraﬁsh's eyes. A pool of three zebraﬁsh's eyes were used for
each group. Data are expressed as mean ± SEM of ﬁve independent experiments. Data
were analyzed by one-wayANOVA followedby Tukeypost-hoc test. The * represents a sig-
niﬁcant difference from the control group. *p b 0.05.
Fig. 1. Effects of glucose treatment up to 14 days on blood glucose levels. (A) 55.5mMglu-
cose, (B) 111 mM glucose and (C) 166 mM glucose. At least nine zebraﬁsh were used for
each group. Data are expressed as mean ± SEM of nine independent experiments. Data
were analyzedby one-wayANOVA followedby Tukeypost-hoc test. The * represents a sig-
niﬁcant difference from the control group. ***p b 0.001 and **p b 0.01.
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100 μM glimepiride was able to reduce 64% of the blood glucose levels
provoked by 111 mM glucose treatment (from 8.71 ± 2.22 mM to
4.43 ± 0.56 mM) [F(3; 13) = 63.68; p b 0.001] (Fig. 4A), and 63% in
the glucose washout group (from 5.23 ± 0.32 mM to 1.94 ±
0.16 mM) [F(3;20) = 53.48; p b 0.001] (Fig. 4B). The treatment
with 10 μM of metformin was able to reduce 51% of the blood glucose
levels provoked by 111 mM glucose treatment (from 9.21 ± 1.12 mM
to 4.69 ± 1.77 mM) [F(3,49) = 99.72; p b 0.0001], and 45% in the glucose
washout group (from 5.20±0.55mM to 2.36mM±0.66mM) [F(3,39)=
47.77; p b 0.0001] (Fig. 4C and D, respectively). The anti-diabetic drugs
alone did not affect the control glycemia (Fig. 4).
3.4. Effect of hyperglycemia on insulin receptors expression in skeletal
muscles of zebraﬁsh
To evaluate if the hyperglycemia could alter the relative gene ex-
pression of insulin receptors in skeletal muscles, real-time quantitativePCR analyses were performed. Our results demonstrated that the ex-
pression levels of insulin receptor subunit genes (insra-1, insrb-1 and
insrb-2) were increased (insra-1 (97.5%) [F(2; 17) = 8.040; p b 0.05],
insrb-1 (48%) [F(2;16) = 6.288; p b 0.01] and insrb-2 (44.5%) [F(2;16) =
5.92; p b 0.05]) in the washout group when compared to the control
group (Fig. 5 A, C and D). However, there were no statistical relevant
changes in insra-2 gene (Fig. 5B).3.5. Impaired response to insulin
As the above analyses assemble possible information on insulin re-
sponse impairment, we submitted glucose-treated animals to an injec-
tion of insulin in three different doses: 0.01 U/kg, 0.1 U/kg and 1 U/kg.
Our results demonstrated that 0.01 U/kg and 0.1 U/kg doses were un-
able to reverse the hyperglycemic effect caused by the treatment with
111mM glucose solution or to reduce glucose blood level of the control
group (data not shown). However, the 1 U/kg dose was able to decrease
20–32% of the basal blood glucose levels of the control group (Fig. 6A:
from 2.80 ± 0.18 mM to 2.27 ± 0.09 mM and Fig. 6B: from 2.01 ±
0.14 mM to 1.36 ± 0.1 mM) [p b 0.05 and p b 0.01, respectively],
while the same dose was unable to decrease the hyperglycemia from
111 mM glucose treated animals (Fig. 6A). In the washout group
(Fig. 6B), the 1 U/kg dose was able to decrease 39% of the blood glucose
levels (from 4.01± 0.32mM to 2.58± 0.32mM) [p b 0.01]. This proto-
col requires a prior anesthesia with tricaine, which could be the reason
for the variability of the blood glucose levels from 111 mM glucose-
treated animals (4.53 ± 0.68 mM) as discussed by Eames et al. (2010).
Fig. 4. Effect of anti-diabetic drug administration on 2% glucose treated and washout groups. Effect of glimepiride (100 μM) (A) and metformin (10 μM) (C) on blood glucose levels of
zebraﬁsh exposed to 111 mM glucose. Effect of glimepiride (100 μM) (B) and metformin (10 μM) (D) on blood glucose levels of zebraﬁsh after a glucose washout period. At least ten
zebraﬁsh were used for each group. Data were analyzed by one-way ANOVA followed by Tukey post-hoc test. The * represents a signiﬁcant difference from the control group. The #
represents a signiﬁcant difference from the 2% glucose group. *p b 0.05, **p b 0.01; ***p b 0.001 and #p b 0.01.
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In the present study, we described persistent features of impaired
glucose metabolism in adult zebraﬁsh exposed to a solution of
111 mM glucose during 14 days. The lowest mortality was seemed in
animals treatedwith 111mMof glucose (20%). However, the highmor-
tality observed in 55.5 and 166 mM glucose-treated animals can be re-
lated to reduced oxygenation and/or osmotic stress.
In this work we reached similar high blood glucose levels as the for-
mer work designed by Gleeson et al. (2007). Here, all glucose solutions
promoted high blood glucose levels after 48–72 h after exposure. After
the glucose withdrawal by 7 days, the blood glucose levels were still
elevated, but lower than the 111 mM glucose group. However, as the
blood glucose levels of thewashout group remained signiﬁcantly higher
than the control group, a long time course observation should be inter-
esting to observe when/if levels return to normal.
In order to verify if persistent hyperglycemia could change a classical
parameter of DM diagnostic, as glycosylation of proteins, we evaluated
the fructosamine levels from zebraﬁsh eyes. Our results demonstrated
that there is an increase of fructosamine levels from zebraﬁsh eyes
treated with 111 mM glucose, which persists in the washout group. Al-
though, traditionally glycosylated hemoglobin (HbA1c) has been used
to monitor glycemic control in DM, unfortunately we could not analyze
the HbA1c levels in blood zebraﬁsh considering the needed volume of
blood for this procedure. However, several studies have demonstrated
that fructosamine and HbA1c levels have been shown as an appropriate
index of glycemic control in DM patients (Juraschek et al., 2012; Lee
et al., 2013).To assist in deﬁning the mechanisms involved in persistent hyper-
glycemia developed for this model, we used two normoglycemic
drugs with different mechanisms: metformin chloridate (biguanide)
and glimepiride (sulphonylurea). Our results demonstrated that the
metformin treatment by 4 days was able to decrease the blood glucose
levels in hyperglycemic zebraﬁsh. Metformin is often recommended as
the ﬁrst line drug in patients with type 2 diabetes (Nathan et al., 2009;
ADA, 2013), because this oralmedication has an effect on the regulation
of glucose uptake, gluconeogenesis, glycolysis and glycogen synthesis
(McIntyre et al., 1991; Shaw et al., 2005). Metformin increases the
activity of the insulin receptor and enhances glucose uptake via in-
creased translocation of glucose transporters, such as GLUT-1 and
GLUT-4 to the plasma membrane (Gunton et al., 2003; Yang and
Holman, 2006). As a result, metformin enhances the insulin-mediated
suppression of gluconeogenesis (Bailey and Turner, 1996). However
the progressive nature of type 2 diabetes, leads to a decline in endoge-
nous insulin secretion, thus the use of a seconddrug, such as glimepiride,
is suggested.
The glimepiride treatment, proved to be effective for lowering blood
glucose levels in zebraﬁsh after 24 h of exposure. The main mechanism
of action of glimepiride is on the activation of ATPase-dependent potas-
sium channels in β cells of the pancreaswhich stimulates insulin release
(Campbell, 1998), leading to a decrease in hexokinase binding to porin
proteins and an increase in the expression of hexokinase mRNA
(Hällsten et al., 2002). Several studies demonstrated that glimepiride
is able to stimulate insulin secretion, but these studies also demonstrat-
ed important extrapancreatic effects, such as activation of glucose trans-
port and glucose-metabolizing enzymes leading to stimulation of
Fig. 5. Effect of 111mM glucose treatment for 14 days and washout of 7 days on (A) insra-1, (B) insra-2, (C) insrb-1 and (D) insrb-2 gene expression in the skeletal muscle of zebraﬁsh. At
least four zebraﬁsh were used for each group. Data are expressed as mean± SEM of experiments performed in quadruplicate. Data were analyzed by one-way ANOVA followed by Tukey
post-hoc test. The * represents a signiﬁcant difference from the control group. *p b 0.05 and **p b 0.01.
Fig. 6. Effect of insulin administration (1 U/kg) on blood glucose levels from the 111 mM
glucose treated group (A) and the washout group (B). At least eleven zebraﬁsh were
used for each group. Data are expressed as mean ± SEM. Data were analyzed by t-test.
The * represents a signiﬁcant difference from the control–saline group. The # represents
difference from the washout–saline group. **p b 0.01 and #p b 0.01.
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cascade, and inhibition of lipolysis (Briscoe et al., 2010). According to
Muller et al. (1995), glimepiride seems to exert pleiotropic effects via
two independentmechanisms: the stimulation of speciﬁc protein phos-
phatases responsible for the regulation of GLUT-4 translocation and gly-
cogen synthase/glycerol3-phosphate acyltransferase activity; and the
stimulation of cAMP-speciﬁc phosphodiesterase (Muller and Wied,
1994; Muller et al., 1995; Muller and Geisen, 1996).
If the successful effects of glimepiride were related to increased
insulin secretion, this lowering of blood glucose levels should be
mimicked by exogenous insulin. We injected insulin in the control,
111 mM glucose-treated and washout animals. Exogenous insulin
was able to reduce blood glucose levels in all groups except in
those from the glucose-treated group. The insulin resistance
state is related to an impaired insulin action and it is believed that
this resistance leads to hyperinsulinemia when β-islets produce a
large amount of insulin in an effort to control the blood glucose
level (Pessin and Saltiel, 2000; Ye, 2013). Even though an insulin
level measurement should be mandatory in this approach, we
failed in the collection of the required blood sample using an
immunoenzymatic assay for quantitative determination of insulin
from serum (Insulin SYM Kit, Symbiosis Diagnostica LTDA, São
Paulo, Brazil). Gathering such information, the glimepiride effects
observed could be more related to extrapancreatic effects than its
well-known effect of stimulating insulin secretion.
The insulin responsive tissues express insulin receptors (IRs) at the
cell surface plasma membrane. After the IR has been activated, they
generate second messengers that activate a cascade of phosphorylation–
dephosphorylation reactions resulting in the stimulation of intracellular
glucose metabolism (Kahn et al., 1993;Whitehead et al., 2000). Dysfunc-
tions of the IR and components of signaling cascade result in insulin re-
sistance that leads to type 2 diabetes mellitus (Tseng et al., 2009). The
64 K.M. Capiotti et al. / Comparative Biochemistry and Physiology, Part B 171 (2014) 58–65IRs of zebraﬁsh were identiﬁed and characterized by Toyoshima et al.,
who demonstrated two isoforms of the IRs in zebraﬁsh, Insra and
Insrb, which are homologous to human IRs (Toyoshima et al., 2008).
Several proteins have been identiﬁed in zebraﬁsh as components of glu-
cose metabolism, as glucose transports (GLUTs) and phosphoenolpyr-
uvate carboxykinase (PEPCK), which have similar regulation patterns
and activity as seen in mammalian counterparts (Taniguchi et al.,
2006; Elo et al., 2007).
Interestingly, our results demonstrated that the mRNA expression
levels of insra-1, insrb-1 and insrb-2were signiﬁcantly increased in the
washout group, promoting a classical mechanism known as up-
regulation, which could explain the partial reduction of glycemia in
the washout group and the rescue of response to exogenous insulin.
Other studies demonstrated that the kinetics of the insulin signaling
via insra is similar to the mammalian insulin signaling cascades, sug-
gesting that the signaling pathways downstream of the zebraﬁsh IR
are the same as found in other vertebrates (Stumvoll et al., 1995;
Toyoshima et al., 2008). During early development of zebraﬁsh the
two IRs appear to play differently, whereas insra is critical for brain
development and for general growth, insrb is essential for proper
heart development (Stumvoll et al., 1995; Toyoshima et al., 2008).
5. Conclusions
In summary, our data demonstrated that the exposure of zebraﬁsh
to glucose diluted in water during 14 days promoted persistent high
blood glucose levels, glycation of proteins of the eyes and impaired re-
sponse to exogenous insulin. The hyperglycemic statewas counteracted
by biguanide and sulphonylurea drugs, probably by the increase of pe-
ripheral tissue response to insulin and not by pancreatic secretion of in-
sulin, since exogenous insulin was ineffective. The glucose withdrawal
of 7 days was able to partially recover some consequences of glucose
exposure, probably by the recovery of insulin response, through an in-
crease of insulin receptors in muscle. This study attempts to establish
zebraﬁsh as a valuable model for the study of targets applicable to
diabetes. Zebraﬁsh may be an ideal model to study the different mech-
anisms affected by hyperglycemia, as well as to understand the link
between the central nervous system function and the alterations in
the endocrine system, such as in DM.
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